中国癌症研究基金会第4届理事会主席讲话

（２００２年８月１６日）感谢同志们的信任 ,推举我担任中国癌症研究基金会的主席。我将尽力为理事会服务。今天 ,中国癌症研究基金会第４届理事会及其领导机构已经产生。对此 ,我表示衷心的祝贺。相信同志们会对我国癌症研究及其防治事业做出更大的贡献。谈到中国癌症研究基金会 ,自然会想到李冰同志。她是基金会的创建者 ,也是我国癌症防治事业的奠基者之一。她为查清我国癌症流行情况、组建防治队伍以及在高发区开展综合防治研究等方面作出了杰出的贡献。虽然她已经离开了我们 ,但是她的精神对基金会永远是一个激励。我们要按照基金会的…     

政府购买公共卫生服务与中国癌症基金会的发展

摘 要：近年来,党和政府出台一系列政策推进政府购买社会组织服务。在公共卫生领域,政府已经开展购买服务项目并积累了一定经验。为满足癌症防控工作的需要,社会组织应当积极承接政府购买服务项目。政府购买服务项目可以对中国癌症基金会的发展起到促进作用,中国癌症基金会也可以通过参与项目,在癌症防治领域发挥积极作用。     

肿瘤学社团组织积极参与癌症控制

我国几十年的肿瘤防治研究工作所取得的成就与各级政府部门的重视是分不开的。同时广大的肿瘤学专家、学者以及献身于抗癌事业的各界人士和肿瘤科研机构、医药研究机构、企业等自发组织成的社会团体对我国的抗癌事业作出的努力也是功不可没的。这些社会团体协助政府支持抗癌防癌工作,在提高肿瘤防治研究水平,促进肿瘤科技人才的培养和提高,普及抗癌知识和技术等各领域中起到了积极作用。现就中国癌症研究基金会和中国抗癌协会的情况作一介绍。中国癌症研究基金会中国癌症研究基金会（CCR）成立于1984年,是唯一的全国性癌症基金组织,1…     

中国癌症现场防治研讨会纪要

由中国癌症研究基金会、全国肿瘤防治研究办公室主办，江苏启东肝癌防治研究所承办的“中国癌症现场防治研讨会”于2002年12月8日～9日在启东市召开。卫生部科教司、疾控司、科技部农社司、中国癌症研究基金会、全国肿瘤防治研究办公室的领导(代表)，以及北京、河南、河北、山东、江苏、浙江、广东、云南、广西等地癌症防治现场的负责同志与专家50余人出席了会议。研讨会邀请了多年从事癌症现场防治的有关专家就肝癌及胃癌的综合防治，大肠癌、食管癌、鼻咽癌及宫颈癌的早诊早治作了专题报告。这些精彩的报告充分展示了我国癌症现场防治研究…     

中国癌症研究基金会章程

（２００２年８月１６日第４届理事会通过）第一章总则第一条中国癌症研究基金会（以下简称本基金会）为全国性基金组织。本基金会属非营利性社会团体 ,独立社团法人。第二条本基金会英文名称为ＣｈｉｎａＣａｎｃｅｒＲｅｓｅａｒｃｈＦｏｕｎｄａｔｉｏｎ；英文简称为ＣＣＲＦ。第三条本基金会宗旨是 :通过从国内外募集资金 ,推进我国癌症研究与防治事业发展。本基金会遵守中华人民共和国宪法以及国家法律、法规和有关政策 ,遵守国家有关基金会管理的规定。活动中维护社会公共利益和道德风尚。第四条本基金会接受其业务主管单位国务院卫生…     

中国癌症研究基金会第4届理事会名誉理事长讲话

（２００２年８月１６日）中国癌症研究基金会召开第４届理事会并产生了新的领导机构 ,我代表卫生部向同志们表示热烈的祝贺 ,祝愿同志们在基金会主席和理事长的领导下对我国癌症研究防治事业作出更大的贡献。建国５０多年来 ,中国卫生事业迅速发展 ,人民健康水平不断提高 ,取得了举世公认的成就。但是 ,随着我国经济和社会的深刻变革和人民生活水平的不断提高 ,以及人们工作环境和生活方式的明显改变 ,我国卫生工作面临一系列新的严峻的挑战。这里既包括对居民健康的影响 ,也包括对保健制度的挑战。以对居民健康的影响而言 ,人口学的变化 ,…     

中国癌症基金会

中国癌症基金会原名中国癌症研究基金会,成立于1984年10月26日,是我国致力于癌症防治的公益性组织,全国性公募基金会,独立社团法人。我国癌症防治事业的奠基人之一、著名肿瘤放射治疗专家吴桓兴教授,原卫生部部长陈敏章教授及卓越的肿瘤防治事业开拓者李冰教授曾先后担任基金会主席。     

中国癌症研究基金会首届医院管理会议简讯

中国癌症研究基金会首届医院管理会议于1992年9月25日至28日在北京劳动大厦举行。全国30余家中国癌症研究基金会医疗成员单位,44位院长及部分地区卫生局负责同志参加了会议。会议期间代表们交流了各种办医形式以及科技兴医的经验,充分肯定了中国癌症研究基金会在肿瘤防治研究工作以及社会办医中的支持和组织协调作用。中国癌症研究基金会李冰理事长就如何发挥国家、集体、个人积极性,动员社会,办好肿瘤防治事业讲了话;肯定了中国癌症研究基金会所属医疗单位在肿瘤防治研究工作中的成绩,对今后的工作提出了要求和     

中国癌症研究基金会第4届理事会理事长讲话

（２００２年８月１６日）中国癌症研究基金会成立以来癌症基金会的同志们和全国肿瘤防治工作者一道 ,做了很多有益的工作。对此 ,我和新一届理事会的同志们表示由衷的敬意。此次中国癌症研究基金会的换届是在卫生部的直接领导下进行的。现在 ,新的理事会及其领导机构已经产生 ,同时还对基金会的章程进行了必要的修改。所有这些都使基金会更能适应国家日益发展的形势及其对社团管理的要求。基金会章程是基金会活动及管理的基本依据 ,希望我们各级人员自觉地遵守基金会章程 ,促进基金会的健康发展。显然 ,本次基金会的换届及章程的修订使基金…     

癌症高发现场防治工作会议简报

2005年5月10日至12日，由卫生部疾病控制司、中国癌症研究基金会、全国肿瘤防治研究办公室主办，河北医科大学第四医院承办的“癌症高发现场防治工作会议”在石家庄市举行。原卫生部副部长、中国癌症研究基金会理事长彭玉，卫生部疾病控制司慢病处处长孔灵芝，全国肿瘤防治研究办公室副主任鲁凤珠等有关领导出席会议。     

Cancer control research 2001

Objectives: Major societal changes, including the changing demographics of US society and the genetics and communications revolutions, are providing new opportunities to control cancer both in the United States and around the world. This article examines the implications of these trends and other issues in the context of cancer control research. A seven-item strategy for cancer control research is proposed. Results: Epidemiology, statistics, genetics, and bio-behavioral research are central disciplines for cancer control research. The identification of particular at-risk populations is increasingly possible. Cancer control research must focus on increasing fundamental knowledge in order to accelerate improvements in cancer prevention and early detection. Cancer control research also must be used to conduct trials of new cancer detection methods, overcome differential participation in cancer screening, develop evidence-based strategies to improve decision-making, and develop evidence-based cancer communications. A comprehensive cancer surveillance system is the foundation for cancer control research. Cancer control research must aim to reduce cancer risk, incidence, and mortality, and improve quality of life. These are important challenges for the new millennium.     

Update on Cancer Prevention Research in the United States and China: the 2009 China--U.S. Forum on Frontiers of Cancer Research

Cancer is one of the major physical, social, and economic burdens and public health threats worldwide. Citizens everywhere face the challenge of dealing with the costs and devastation of this dreadful disease regardless of country of residence. In October 2009, a joint China-U.S. forum focusing on cancer prevention was held in Changsha, China. The goal of this timely joint conference was to provide a forum for the exchange of the most recent and relevant information on cancer control, translational cancer prevention research, and clinical trials in China and the United States. The scientifically driven symposium comprised didactic sessions that included discussions focused on identifying and validating effective chemopreventive agents and their molecular and cellular targets. A major highlight of the meeting was the participation of Chinese and American experts from Xiangya Medical School, Central South University and the Center for Health Policy and Management (China), and the National Institutes of Health (NIH, United States), who provided a unique insight into each country's public efforts and progress in cancer prevention. Participants clearly agreed that our current understanding of the many factors influencing cancer causation indicates that as much as two thirds or more of human cancers can be prevented. This perspective presents an overview of the progress being made in cancer prevention in China and the United States.     

Cancer Research and Control Activities in Japan - Contributions to International Efforts

Since the establishment of the Japanese Foundation for Cancer Research in 1908, Japan has experienced along history of physicians and researchers playing very active roles in both national and international effortsfor cancer control. With the opening of the Japanese Foundation for Cancer Research Cancer Institute andHospital in 1934 and the National Cancer Center in 1962, followed by Aichi Cancer Center in 1964 and thengraduallyt Prefectural Centers across the country, the populace is well endowed with specialist research andclinical facilities. Under the Cancer Control Act, implemented in 2007, these are now being complemented by anetwork of specialist hospitals also involved in efforts to improve training and cancer registration as well asstandardization of cancer treatment. Regional cancer registries have been active since the 1960’s and nationalprograms for cervical and stomach cancer screening were introduced in 1984. Subsequently, such early detectionefforts have been added for the lung, colorectal, endometrial and breast cancers. There are a large number ofacademic scientific societies holding regular research meetings and focusing on all the different aspects of cancercontrol. In addition, there are non-government organizations like the Foundation for Promotion of CancerResearch, the Princess Takamatsu Cancer Research Foundation, the Sapporo Cancer Seminar Foundation andthe Hiroshima Cancer Seminar Foundation, all sponsoring international research meetings and other efforts.Other foundations have been established, for example by patient support groups, and policy research and strategicplanning are now high priorities of the Government. Japan also continues to contribute to international effortsthough its membership in the WHO and the International Agency for Research on Cancer (IARC), as well asthrough individual memberships in the Intrnational Union Against Cancer (UICC).     

Chinese Anti-Cancer Association as a non-governmental organization undertakes systematic cancer prevention work in China

Cancer has become the first leading cause of death in the world, particularly in low- and middle-income countries. Facing the increasing trend of cancer incidence and mortality, China issued and implemented “three-early (early prevention, early diagnosis and early treatment)” national cancer prevention plan. As the main body and dependence of social governance, non-governmental organizations (NGOs) take over the role of government in the field of cancer prevention and treatment. American Cancer Society (ACS) made a research on cancer NGOs and civil society in cancer control and found that cancer NGOs in developing countries mobilize civil society to work together and advocate governments in their countries to develop policies to address the growing cancer burden. Union for International Cancer Control (UICC), Cancer Council Australia (CCA), and Malaysian cancer NGOs are the representatives of cancer NGOs in promoting cancer control. Selecting Chinese Anti-Cancer Association (CACA) as an example in China, this article is to investigate how NGOs undertake systematic cancer prevention work in China. By conducting real case study, we found that, as a NGO, CACA plays a significant role in intensifying the leading role of government in cancer control, optimizing cancer outcomes, decreasing cancer incidence and mortality rates and improving public health.     

中国癌症控制策略研究报告

[目的]探讨中国癌症控制策略。[方法]采用文献检索，资料研究，专家讨论等方法。[结果]报告世界和中国癌症流行趋势及防治现状；提出中国癌症控制目标、重点、主要干预措施；明确中国癌症防治信息系统的建设及中国癌症防治管理的措施。[结论]该研究结果符合中国国情，有利于国家癌症控制规划及计划的制定与实施。     

American Cancer Society Perspectives on Environmental Factors and Cancer

Cancer prevention is central to the mission of the American Cancer Society (ACS). The ACS's prevention activities take many forms, but are primarily focused on modifiable risk factors that have been demonstrated to have the largest impact on cancer risk in the general population (with particular emphasis on tobacco use because of its large impact on cancer), and well‐proven policy and program interventions. The ACS addresses nutrition, physical inactivity and obesity, alcohol consumption, excessive sun exposure, prevention of certain chronic infections, and selected other environmental factors through a variety of venues, including consensus guidelines (eg, nutrition and physical activity, human papillomavirus vaccination) and developing educational materials for health care providers and the general public. In contrast to the broad definition of environmental factors used by the ACS and most other public health agencies, some members of the general public associate the term “environmental” only with toxic air and water pollutants and other, predominantly manmade, hazards that people encounter, often involuntarily, in their daily life. This article will provide an overview of the ACS's approach to the prevention of cancer associated with such toxic pollutants in the context of its mission and priorities with respect to cancer prevention. CA Cancer J Clin 2009. © 2009 American Cancer Society.     

浙江省4个肿瘤登记地区2004年恶性肿瘤发病资料分析

[目的]探讨浙江省4个肿瘤登记地区人群恶性肿瘤发病的流行特征。[方法]对浙江省4个肿瘤登记处七报浙江省肿瘤防治办公室的2004年肿瘤发病资料，根据《中国肿瘤登记工作指导手册》以及国际癌症研究中心和国际癌症登记协会推荐的肿瘤登记原则和方法，进行分类、审核和分析。[结果]2004年4个肿瘤登记处共报告新发病例数为16709例，其中男性为9783例．女性为6926例。恶性肿瘤发病世调率为189．38／10万，最高的嘉兴市为216．40／10万，余依次为杭州市194．47／10万，嘉善县162．42／10万，海宁市143．29／10万；2004年发病前10位恶性肿瘤为肺癌、胃癌、肝癌、乳腺癌、结肠癌、直肠癌、食管癌、脑肿瘤、胰腺癌及白血病。[结论]肺癌、消化系统恶性肿瘤、乳腺癌应作为浙江省4个肿瘤登记地区肿瘤防治工作的重点。     

Programs for Asian Pacific Cancer Prevention in Response to the Four Strategic Directions of UICC for the New Millennium

The final goal of epidemiology is the establishment of prevention measures and the promotion of better human ‍health. The information we obtain through research needs to be substantially supplemented by comprehensive ‍knowledge of the standardized “global strategy”. To establish regional cancer control programs, we need basic data ‍on cancer incidence and mortality in the general populace gained from well-organized cancer registration and collection ‍of vital statistics. Cancer is a typical lifestyle related disease and we should define the risk and protective factors for ‍cancer in particular peoples. In general, lifestyle is established by long-term acquired culture in each ethnic group ‍and area, and we cannot easily transfer established cancer control programs from developed countries to other ‍states with a very different cultural background. We need to establish our own cancer control strategy that would be ‍accommodating our own physical and social environments. This was the reason why the Asia Pacific Organization ‍for Cancer Prevention ( APOCP) was set up to promote all aspects of cancer prevention across our own area of the ‍globe. The idea of a Practical Prevention Program (PPP) pilot center in Asia was a well-timed proposal and to now ‍promote the PPP, continuous grass route activity by core persons and institutions, accompanied by positive ‍participation of the general populace, is indispensable. The APOCP and the UICC should play central roles in providing ‍rear-area logistic support to promote local activities on cancer control. What we learn here in the Asian Pacific will ‍also be of great assistance to efforts in other areas of the world. ‍     

National Cancer Control Program of Thailand

Since 2000 cancer has been the leading cause of death in Thailand. In response to this challenge, the National Cancer Institute of Thailand (NCI), in collaboration with other bodies, has developed and promoted the National Cancer Control Program (NCCP) to provide appropriate policies and practice for the prevention, early detection and treatment of cancer, with optimal supportive care. With plans strongly supported by the Ministry of Public Health, the NCCP envisages integration into the health care system in 6 strategic areas: (1) cancer informatics; (2) primary prevention; (3) early detection; (4) treatment; (5) palliative care; and (6) cancer control research. For this purpose 7 regional cancer hospitals have been established to aid the NCI in conducting the NCCP. Cancer registration is a high priority, with 31.2% of the population now covered by quality registries. In primary prevention, there is a focus on awareness, lifestyle improvement, anti-smoking and alcohol control programs, vaccination, and Opisthorchis viverrini (OV) control. Screening programs for cervical, breast and colorectal cancer are underway to increase early detection. Priority is being given to facilities for chemotherapy and radiotherapy, as well as palliative care. Cancer control research encompasses international cooperation and participation in training programs, especially for development of cancer registration and other aspects of cancer control programs in South-East Asia, not least as an IARC Collaborating Center.     

Cancer control activities in the Republic of Korea

South Korea has a population of 47.3 million. The whole population is covered by a mandatory social insurance system (the National Health Insurance Program) that is financed through the contributions paid by the insured and their employers. Cancer has been the leading cause of death in Korea since 1983. About 130 000 people develop cancer annually with 66 000 deaths in 2006. Cancer patients' 5-year survival rates between 1998 and 2002 were 37.8 and 57.0% for men and women, respectively. The five leading primary cancer sites were stomach, lung, liver, colon and rectum, and bladder among males, whereas the most common cancers were stomach, breast, colon and rectum, uterine cervix and lung among females. With the rapidly aging population, reducing cancer burden at the national level has become one of the major political issues in Korea. The government formulated its first 10-year plan for cancer control in 1996. In 2000, the National Cancer Center was created and the Cancer Control Division was set up within the Ministry of Health and Welfare. The Cancer Control Act was legislated in 2003. Korea's major national cancer control programs are anti-smoking campaigns, hepatitis B virus vaccination, cancer registration and networking, promotion of R&D activities for cancer control, education and training for cancer control and prevention, operation of the national cancer information center, operation of the mass screening program for five common cancers, management of cancer patients at home, financial support for cancer patients and designation of regional cancer centers.